Home/IPOs/AMANTA

AMANTA IPO

Amanta Healthcare Limited

IPO Doc

Start Date01-09-2025

Application Timing10am-5pm

Price Range₹120 - ₹126

Min Qty119

Min. Investment₹14280

Listing Date09-09-2025

Close Date03-09-2025

About Amanta Healthcare Limited

Incorporated in 1994, Amanta Healthcare Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of sterile liquid products. The company specializes in parenteral products packaged using advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies.

Amanta Healthcare also manufactures medical devices including irrigation solutions, eye lubricants, and first-aid products. Its product portfolio covers IV fluids, diluents, ophthalmic solutions, and respiratory care products.

The company operates through three business units – National Sales, International Sales, and Product Partnering – with a presence in 19+ countries, including Africa, Latin America, and the UK. In FY25, Amanta exported branded products to 21 countries.

With a workforce of over 1,700 employees, the company markets more than 45 generic products in India through 320 distributors and stockists, supported by a strong domestic and international network.

Why To Invest in Amanta Healthcare Limited

Strong Market Presence: Established player in the pharmaceutical industry with a diverse product portfolio across formulations and medical devices.

Global Reach: Products registered in multiple countries and strong exports to emerging as well as developed markets.

Financial Growth: Despite a slight dip in revenue, PAT grew by 189% YoY in FY25, reflecting strong operational efficiency.

Healthy Margins: EBITDA margin of 22.11% and PAT margin of 3.86% indicates improving profitability.

Expansion Plans: IPO proceeds will be used to fund new manufacturing lines at Hariyala, Gujarat, enhancing production capacity.

Experienced Management: Led by promoters with decades of experience in pharmaceuticals and healthcare manufacturing.

Financial Table

Period Ended	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	381.76	352.12	374.06
Total Income	276.09	281.61	262.70
Profit After Tax	10.50	3.63	-2.11
EBITDA	61.05	58.76	56.31
Net Worth	96.39	66.29	62.88
Reserves and Surplus	67.56	39.46	36.05
Total Borrowing	195.00	205.23	215.66

Strengths And Risks

Well-Established Pharmaceutical Company: Amanta Healthcare has a long track record in the pharma sector with a wide and diverse product base, ranging from IV fluids to medical devices. This strong foundation enhances its credibility and growth potential.

Strong Domestic and International Network: The company has a robust marketing presence in India through 320 distributors and stockists, along with a global footprint across Africa, Latin America, the UK, and other regions. Its international expansion provides stability and diversified revenue streams.

Large-Scale Manufacturing Capabilities: With advanced facilities utilizing ABFS and ISBM technologies, Amanta Healthcare is capable of producing a high volume of sterile liquid products, ensuring consistent supply to meet rising market demand.

Skilled Workforce and Experienced Management: A team of more than 1,700 employees and a promoter group with decades of industry experience strengthen the company’s operational efficiency and long-term vision.

High Debt Levels: The company carries a Debt-to-Equity ratio of 2.02, which indicates a high dependence on borrowings. This could affect profitability if debt servicing costs rise.

Declining Revenue Trend: Although profits improved, revenue in FY25 witnessed a 2% decline compared to FY24, reflecting challenges in top-line growth. Sustained revenue expansion remains critical for long-term performance.

Dilution of Promoter Holding: Promoter shareholding will reduce significantly from 85.60% pre-IPO to 63.56% post-IPO, which may impact promoter control and investor confidence.

High Valuation Concerns: At a Post-issue P/E of 46.59x, the IPO is priced on the higher side compared to some industry peers. This raises concerns regarding its valuation attractiveness for investors.

FAQs

What are the IPO dates for Amanta Healthcare Ltd? +

What is the issue size of Amanta Healthcare IPO? +

What is the price band of the IPO? +

When is the allotment and listing date? +

Who are the promoters of the company? +

E-IPO

Get In On The Action EarlyBuy cheap, earn big. Discover IPOs with the highest growth potential early and invest now through Rupeezy to earn big in the future.

Explore Other Products

Rupeezy AppAdvanced charts, advanced Option Chain, instant pay-in & pay-out,margin .Learn More

Rupeezy <> TradingViewEnjoy top-class trading experience enhanced by advanced TradingView charts.Learn More

DockPortfolio analysis, pledge holdings, apply in IPOs & download reports Learn More

3rd Floor, Incubex INR4, 777c, 100 Feet Rd, HAL 2nd Stage, Indiranagar, Bengaluru, Karnataka 560038

0755-4268599, 0755-6693322

support@rupeezy.in

Download the Rupeezy App now

Products

NFO

Platform

Rupeezy <> TradingView

Partner App (MFD)

Partner Login

Features

Iceberg

MF Lab

Smart Explore

T+5

Business

Become an MFD

Become an AP

Authorized Person Lists

Help

Company

Astha Credit & Securities Pvt Ltd NSE, BSE & MCX SEBI Reg No:

INZ000187932

Membership ID:

NSE - 12227 BSE-6844 MCX - 40000 NSDL-IN303420 CDSL-94500

CIN:

U65929MP2003PTC016241

SEBI Depository Participant Reg No:

IN-DP-611-2021

For any grievance contact:

grievance@rupeezy.in
0755-4268599

For cyber attack incident reporting:

gyanesh@rupeezy.in
9669695615

SEBI RA Registration:

INH000013332

AMFI Registration:

ARN-35911

Attention Investors:

Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Do not keep funds idle with the Stock Broker. Please note that your stock broker has to return the credit balance lying with them, within three working days in case you have not done any transaction within last 30 calendar days. Please note that in case of default of a Member, claim for funds and securities, without any transaction on the exchange will not be accepted by the relevant Committee of the Exchange as per the approved norms.
Check the frequency of accounts settlement opted for. If you have opted for running account, please ensure that your broker settles your account and, in any case, not later than once in 90 days (or 30 days if you have opted for 30 days settlement). In case of declaration of trading member as defaulter, the claims of clients against such defaulter member would be subject to norms for eligibility of claims for compensation from IPF to the clients of the defaulter member. These norms are available on Exchange website at following link: https://www.nseindia.com/invest/about-defaulter-section.
Brokers are not permitted to accept transfer of securities as margin. Securities offered as margin/ collateral MUST remain in the account of the client and can be pledged to the broker only by way of ‘margin pledge’, created in the Depository system. Clients are not permitted to place any securities with the broker or associate of the broker or authorized person of the broker for any reason. Broker can take securities belonging to clients only for settlement of securities sold by the client.
Always keep your contact details viz. Mobile number/Email ID updated with the stock broker. Email and mobile number is mandatory and you must provide the same to your broker for updation in Exchange records. You must immediately take up the matter with Stock Broker/Exchange if you are not receiving the messages from Exchange/Depositories regularly.
Don't ignore any emails/SMSs received from the Exchange for trades done by you. Verify the same with the Contract notes/Statement of accounts received from your broker and report discrepancy, if any, to your broker in writing immediately and if the Stock Broker does not respond, please take this up with the Exchange/Depositories forthwith.
Check messages sent by Exchanges on a weekly basis regarding funds and securities balances reported by the trading member, compare it with the weekly statement of account sent by broker and immediately raise a concern to the exchange if you notice a discrepancy.
Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.

Precautions for clients dealing in Options

Sharing of trading credentials i.e. login id & passwords including OTP’s is prohibited.
Trading in leveraged products like options without proper understanding could lead to losses. Please trade at your own risk.
Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks could lead to losses.
Dealing in unsolicited tips through WhatsApp, Telegram, YouTube, Facebook, SMS, calls, etc should be avoided.
Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers should be avoided.

Awareness regarding guidelines regarding margin collection:

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge
Pay 20% upfront margin of the transaction value to trade in cash market segment
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard
Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month

Advisory – KYC Compliance:

All investors are requested to take note that 6 KYC attributes i.e. Name, PAN, Address, Mobile Number, Email id and Income Range have been made mandatory. Investors availing custodian services will be additionally required to update the custodian details.
The last date to update KYC is on or before March 31, 2022.
Thereafter non-compliant trading accounts will be blocked for trading by the Exchange.
The non-compliant demat accounts will be frozen for debits by Depository Participant or Depository.
On submission of the necessary information to the stockbroker and updation of the same by the stockbroker in the Exchange systems and approval by the Exchange, the blocked trading accounts shall be unblocked by the Exchange on T+1 trading day.
The demat account shall be unfreezed once the investor submits the deficient KYC details and the same is captured by the depository participant in the depository system.
To ensure smooth settlement of trades, the investors are requested to ensure that both the trading and demat accounts are compliant with respect to the KYC requirement.
The investors are hereby requested to comply with the regulatory guidelines issued by Exchanges and Depositories from time to time with regard to KYC compliance and related requirements.
We do proprietary trading

Client Bank Account Details:

Sr. No	Name of Bank Account	Bank Account Number	IFSC Code
1	ASTHA CREDIT AND SECURITIES P LTD - USCNBA A/c	00620340000150	HDFC0000062

*Investors are requested to note that Stock broker Astha Credit and Securities Private Limited is permitted to receive/pay money from/to investor through designated bank accounts only named as client bank accounts. Stock broker Astha Credit and Securities Private Limited is also required to disclose these client bank accounts to Stock Exchange. Hence, you are requested to use following client bank accounts only for the purpose of dealings in your trading account with us. The details of these client bank accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker.

1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in the investor's account. 2. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary.

Disclaimer:

Investment in the securities market is subject to market risks, read all the related documents carefully before investing.
Brokerage will not exceed SEBI prescribed limit.
Please refer to the Risk Disclosure Document issued by SEBI and go through the Rights and Obligations and Do's and Don'ts issued by Stock Exchanges and Depositories before trading on the Stock Exchanges.
For commodities derivatives please note that Commodities Derivatives are highly leveraged instruments.
Before investing in the asset class consider your investment objectives, level of experience and risk appetite carefully.
Mutual fund investments are subject to market risks, read all scheme related documents carefully. Mutual Funds are not an approved product of the Exchanges and any dispute related to this will not be dealt at Exchange platform. ACSPL is a Mutual fund distributor/s registered for Mutual Funds.

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors. We do Pro trading.

Client registration documents in Vernacular languages: Get Documents

Terms and Conditions | Privacy Policy | Investor Charter

Download the App Now!

AMANTA IPO

About Amanta Healthcare Limited

Why To Invest in Amanta Healthcare Limited